Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
30 Sep 2019 Lenvatinib Provides Encouraging Responses in Advanced or Metastatic Thymic Carcinoma Endocrine and neuroendocrine tumours - Anticancer agents & Biologic therapy
29 Sep 2019 Significant PFS Benefit Observed with Veliparib plus Carboplatin and Paclitaxel in Patients with Advanced HER2-negative Breast Cancer and BRCA1/2 Mutations Breast cancer - Anticancer agents & Biologic therapy
29 Sep 2019 Adding Pembrolizumab to Neoadjuvant Chemotherapy Improves Outcome in Early TNBC Breast cancer - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
29 Sep 2019 Final FLAURA Results Demonstrate Overall Survival Benefit with Osimertinib Over TKIs in Advanced NSCLC Lung and other thoracic tumours - Personalised medicine - Anticancer agents & Biologic therapy
29 Sep 2019 LOXO-292 Demonstrates Promising Anti-Tumour Activity in RET-Altered Thyroid Cancer Endocrine and neuroendocrine tumours - Personalised medicine - Anticancer agents & Biologic therapy
29 Sep 2019 Dual HER2 Blockade in Patients With HER2-Amplified Metastatic Colorectal Cancer Gastrointestinal cancers - Personalised medicine - Anticancer agents & Biologic therapy
29 Sep 2019 First-Line Pembrolizumab Versus Chemotherapy in Patients with Advanced G/GEJ Cancer Demonstrates Similar Survival and HRQoL Gastrointestinal cancers - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
29 Sep 2019 Molecular Classification Is Prognostic of Adjuvant Treatment Benefit in Patients with High-Risk Endometrial Cancer Gynaecologic malignancies - Translational research
28 Sep 2019 Gut Microbiota May Support an Immune Tolerant Profile That Affects Ipilimumab Activity Basic science - Cancer Immunology and Immunotherapy
28 Sep 2019 Incorporating Veliparib into Chemotherapy and Continuing with Veliparib Maintenance Significantly Improved PFS in Newly Diagnosed High-Grade Serous Ovarian Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy
28 Sep 2019 Breakthrough from PAOLA1 GINECO/ENgOT-ov25 trial: Adding Olaparib to Bevacizumab Maintenance Demonstrates Substantial Clinical Benefit in Newly Diagnosed Advanced Ovarian Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy
28 Sep 2019 Niraparib Prolongs PFS in Patients with Newly Diagnosed Advanced Ovarian Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy
28 Sep 2019 The Use of Complementary Medicines is Relatively High Among Patients in Phase III Cancer Trials Palliative and supportive care
28 Sep 2019 ctDNA From Patients with Colon Cancer Is Indicative of Outcome Following 3 Versus 6 Months of Oxaliplatin-Based Adjuvant Treatment Gastrointestinal cancers - Translational research
28 Sep 2019 The EPIPHANY Index Assesses Risk of Short-Term Serious Complications in Patients with Cancer and Pulmonary Embolism Palliative and supportive care